SCHEMBL6880649

SCHEMBL6880649

CN(C)c1ccnc(N[C@H]2CC[C@@H](NC(=O)Nc3ccccc3I)CC2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKB Q96GD4 2/20 0.41
MAPK8 P45983 2/20 0.41
MAPK14 Q16539 2/20 0.41
MCHR1 Q99705 8/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
AURKA O14965 1/20 0.41
TTK P33981 1/20 0.41
INCENP Q9NQS7 1/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP2C9 P11712 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
MAPK9 P45984 1/20 0.41
MAPK10 P53779 1/20 0.41
P2RY1 P47900 1/20 0.40
ADRA2A P08913 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6880656 1.00 AURKB (0.41) AURKBMAPK8MAPK14MCHR1KDM4E
SCHEMBL6872853 0.89 EPHX2 (0.47) AURKBMAPK8MAPK14MCHR1MEN1
SCHEMBL6872847 0.89 EPHX2 (0.47) AURKBMAPK8MAPK14MCHR1MEN1
SCHEMBL6869279 0.88 MAPK14 (0.54) AURKBMAPK8MAPK14MCHR1HTT
SCHEMBL6878449 0.88 MAPK8 (0.41) AURKBMAPK8MAPK14MCHR1KDM4E
SCHEMBL6878450 0.88 MAPK8 (0.41) AURKBMAPK8MAPK14MCHR1KDM4E
SCHEMBL6869275 0.88 MAPK14 (0.54) AURKBMAPK8MAPK14MCHR1HTT
SCHEMBL6873991 0.88 MCHR1 (0.43) AURKBMAPK8MAPK14MCHR1KDM4E
SCHEMBL6873985 0.88 MCHR1 (0.43) AURKBMAPK8MAPK14MCHR1KDM4E
SCHEMBL6877414 0.87 KMT2A (0.56) AURKBMAPK8MAPK14MCHR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed